Assistance Publique des Hôpitaux de Paris SA
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 1849-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.aphp.fr
Study of the Effects of Time-Restricted Feeding on the Immune Function of Individuals With Obesity
Not Applicable
Not yet recruiting
- Conditions
- Obesity and Obesity-related Medical Conditions
- First Posted Date
- 2025-03-28
- Last Posted Date
- 2025-03-28
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 24
- Registration Number
- NCT06899997
- Locations
- 🇫🇷
HEGP - digestive surgery, Paris, France
🇫🇷HEGP - nutrition department, Paris, France
Prevention of Postoperative Respiratory Complications
Not yet recruiting
- Conditions
- General AnesthesiaVentilator-Induced Lung InjuriesPostoperative Respiratory Complications
- First Posted Date
- 2025-03-27
- Last Posted Date
- 2025-03-27
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 34
- Registration Number
- NCT06899295
- Locations
- 🇫🇷
AP-HP, Lariboisière Hospital, Department of Anesthesiology and Intensive Care Paris, France, 75010, Paris, Ile de France, France
Pulse Corticosteroids Or/and Immunoglobulins to Treat Fulminant Myocarditis
Phase 2
Not yet recruiting
- Conditions
- Myocarditis Acute
- Interventions
- Drug: Pulse bolus corticosteroidsDrug: Pulse bolus corticosteroids and IVIGDrug: Pulse bolus corticosteroids (G5%) and IVIG (G5 %)
- First Posted Date
- 2025-03-26
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 120
- Registration Number
- NCT06896253
Involvement of the Immune System in Intrinsic Radiosensitivity
Not Applicable
Not yet recruiting
- Conditions
- Neoplasms
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-28
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 40
- Registration Number
- NCT06826066
Safety and Efficacy of Gene Therapy of FHL Type 3 Caused by Mutations in the Human UNC13D Gene by Transplantation of a Single Dose of Autologous CD34+ Cells Transduced Ex Vivo with the UNC13D LV Vector Expressing the UNC13D CDNA
Phase 1
Not yet recruiting
- Conditions
- Familial Hemophagocytic Lymphohistiocytosis Type 3 (FHL 3)
- Interventions
- Drug: MUNC-T3
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 5
- Registration Number
- NCT06736080
- Locations
- 🇫🇷
Hôpital Necker Enfant Malades, Paris, France
Craniopharyngioma and Pregnancies
Recruiting
- Conditions
- Craniopharyngioma
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 100
- Registration Number
- NCT06801756
- Locations
- 🇫🇷
Pitié-Salpêtrière hospital, Paris, France
Efficacy and Safety of Tocilizumab for Acute Chest Syndrome Treatment in Patients with Sickle Cell Disease
Phase 3
Not yet recruiting
- Conditions
- Sickle Cell DiseaseAcute Chest Syndrome
- Interventions
- Drug: Tocilizumab (RoActemra®, 20 mg/mL).Drug: Placebo (NaCl 0.9%)
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 130
- Registration Number
- NCT06818266
- Locations
- 🇫🇷
Department of General Pediatrics and Sickle Cell Center, Necker-Enfants malades Hospital, Paris, France
Variability of Perfusion Index to Predict Hypotension
Not Applicable
Not yet recruiting
- Conditions
- Post-spinal Hypotension
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 45
- Registration Number
- NCT06769750
- Locations
- 🇫🇷
Department of Anesthesia and Intensive Care, Perioperative Medicine, Hôpital Nord,, Marseille, Marseilles, France
Prevention Strategy for Respiratory Syncytial Virus (RSV) Infections in Infants in France
Not yet recruiting
- Conditions
- RSV Infection
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 400
- Registration Number
- NCT06881953
- Locations
- 🇫🇷
Public health department, Hôpital Pitié Salpêtrière, Paris, France
Study of the Association Between Fatigue Experienced by Patients and the Specific Side Effects of CART Cells, During the First Month After Administration for Non-Hodgkin's Lymphoma
Not yet recruiting
- Conditions
- Fatigue SymptomLymphoma Non-HodgkinChimeric Antigen Receptor T-cell TherapyAdverse Events
- First Posted Date
- 2025-03-21
- Last Posted Date
- 2025-03-21
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 100
- Registration Number
- NCT06890091
© Copyright 2025. All Rights Reserved by MedPath